These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 36499287)

  • 1. Pulmonary Fibrosis as a Result of Acute Lung Inflammation: Molecular Mechanisms, Relevant In Vivo Models, Prognostic and Therapeutic Approaches.
    Savin IA; Zenkova MA; Sen'kova AV
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: a potential role for stem cells in the lung parenchyma and implications for therapy.
    Gharaee-Kermani M; Gyetko MR; Hu B; Phan SH
    Pharm Res; 2007 May; 24(5):819-41. PubMed ID: 17333393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis.
    Comeglio P; Filippi S; Sarchielli E; Morelli A; Cellai I; Corcetto F; Corno C; Maneschi E; Pini A; Adorini L; Vannelli GB; Maggi M; Vignozzi L
    J Steroid Biochem Mol Biol; 2017 Apr; 168():26-37. PubMed ID: 28115235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms.
    Mi S; Li Z; Yang HZ; Liu H; Wang JP; Ma YG; Wang XX; Liu HZ; Sun W; Hu ZW
    J Immunol; 2011 Sep; 187(6):3003-14. PubMed ID: 21841134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PI3K/Akt signaling is involved in the pathogenesis of bleomycin‑induced pulmonary fibrosis via regulation of epithelial‑mesenchymal transition.
    Zhang XL; Xing RG; Chen L; Liu CR; Miao ZG
    Mol Med Rep; 2016 Dec; 14(6):5699-5706. PubMed ID: 27878273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressor of cytokine signaling 1 inhibits pulmonary inflammation and fibrosis.
    Nakashima T; Yokoyama A; Onari Y; Shoda H; Haruta Y; Hattori N; Naka T; Kohno N
    J Allergy Clin Immunol; 2008 May; 121(5):1269-76. PubMed ID: 18355908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blocking IL-17A protects against lung injury-induced pulmonary fibrosis through promoting the activation of p50NF-kappaB].
    Mi S; Li Z; Liu H; Hu ZW; Hua F
    Yao Xue Xue Bao; 2012 Jun; 47(6):739-44. PubMed ID: 22919721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ISM1 suppresses LPS-induced acute lung injury and post-injury lung fibrosis in mice.
    Nguyen N; Xu S; Lam TYW; Liao W; Wong WSF; Ge R
    Mol Med; 2022 Jun; 28(1):72. PubMed ID: 35752760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and Molecular Mechanism of Pulmonary Fibrosis Post-COVID-19: Focus on Galectin-1, -3, -8, -9.
    Oatis D; Simon-Repolski E; Balta C; Mihu A; Pieretti G; Alfano R; Peluso L; Trotta MC; D'Amico M; Hermenean A
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy.
    Selman M; King TE; Pardo A; ; ;
    Ann Intern Med; 2001 Jan; 134(2):136-51. PubMed ID: 11177318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Bleomycin Model of Pulmonary Fibrosis.
    Liu T; De Los Santos FG; Phan SH
    Methods Mol Biol; 2017; 1627():27-42. PubMed ID: 28836192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gelsolin expression is necessary for the development of modelled pulmonary inflammation and fibrosis.
    Oikonomou N; Thanasopoulou A; Tzouvelekis A; Harokopos V; Paparountas T; Nikitopoulou I; Witke W; Karameris A; Kotanidou A; Bouros D; Aidinis V
    Thorax; 2009 Jun; 64(6):467-75. PubMed ID: 19213772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pristane/Hypoxia (PriHx) Mouse as a Novel Model of Pulmonary Hypertension Reflecting Inflammation and Fibrosis.
    Mori H; Ishibashi T; Inagaki T; Okazawa M; Masaki T; Asano R; Manabe Y; Ohta-Ogo K; Narazaki M; Ishibashi-Ueda H; Kumanogoh A; Nakaoka Y
    Circ J; 2020 Jun; 84(7):1163-1172. PubMed ID: 32522898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common and distinct mechanisms of induced pulmonary fibrosis by particulate and soluble chemical fibrogenic agents.
    Dong J; Yu X; Porter DW; Battelli LA; Kashon ML; Ma Q
    Arch Toxicol; 2016 Feb; 90(2):385-402. PubMed ID: 26345256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling pathways in the epithelial origins of pulmonary fibrosis.
    Hardie WD; Hagood JS; Dave V; Perl AK; Whitsett JA; Korfhagen TR; Glasser S
    Cell Cycle; 2010 Jul; 9(14):2769-76. PubMed ID: 20676040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo activation of a T helper 2-driven innate immune response in lung fibrosis induced by multi-walled carbon nanotubes.
    Dong J; Ma Q
    Arch Toxicol; 2016 Sep; 90(9):2231-2248. PubMed ID: 27106021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective role of cortistatin in pulmonary inflammation and fibrosis.
    Barriga M; Benitez R; Ferraz-de-Paula V; Garcia-Frutos M; Caro M; Robledo G; O'Valle F; Campos-Salinas J; Delgado M
    Br J Pharmacol; 2021 Nov; 178(21):4368-4388. PubMed ID: 34237151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary toxicity and fibrogenic response of carbon nanotubes.
    Manke A; Wang L; Rojanasakul Y
    Toxicol Mech Methods; 2013 Mar; 23(3):196-206. PubMed ID: 23194015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRPA1: A promising target for pulmonary fibrosis?
    Li C; Xu J; Abdurehim A; Sun Q; Xie J; Zhang Y
    Eur J Pharmacol; 2023 Nov; 959():176088. PubMed ID: 37777106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis.
    Gasse P; Riteau N; Charron S; Girre S; Fick L; Pétrilli V; Tschopp J; Lagente V; Quesniaux VF; Ryffel B; Couillin I
    Am J Respir Crit Care Med; 2009 May; 179(10):903-13. PubMed ID: 19218193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.